---
title: "Science | Lionheart Longevity Investor Relations"
description: "Lionheart Health clinical research, protein targets, Klotho evidence, intellectual property and regulatory position."
url: https://investors.lionheartlongevity.com/science
---

Science

# Science & Clinical Research

The research, evidence and intellectual property behind Lionheart’s bioelectric protein-expression platform.

[Clinical Data Summary →Reported clinical, pilot, observational and preliminary laboratory results by program, plus historical cardiac research.](https://investors.lionheartlongevity.com/science/clinical-data-summary)[Klotho-Up Wellness Study →A 12-month, IRB-approved feasibility study of a combined approach to increasing circulating Klotho, focused on muscle, brain and immune health.](https://investors.lionheartlongevity.com/science/klotho-up-study)[Protein & Signaling Targets →The proteins and signaling targets Lionheart investigates, organized across 24 health areas.](https://investors.lionheartlongevity.com/science/protein-targets)[Klotho Evidence →Potential benefits of Klotho by health area, the type of evidence behind each, and 34 primary-study references.](https://investors.lionheartlongevity.com/science/klotho-evidence)[Intellectual Property →Issued, pending, in-process, licensed and optioned patents, and what the portfolio covers.](https://investors.lionheartlongevity.com/science/intellectual-property)[Regulatory →FDA 510(k) clearances behind the platform, IRB-approved research and the commercialization strategy.](https://investors.lionheartlongevity.com/science/regulatory)[Technology explainers →Bioelectric protein expression, Klotho therapy and encapsulated Klotho-expressing stem cells, in plain language.](https://investors.lionheartlongevity.com/company/technology)